Peter Høngaard Andersen, MD
Chair
Member of the Board since 2020, Chairman of the Board since 2023.
Born: 1956
Position: Member of the Board of Immunovia since 2020, Chairman of the Board since 2023, Member of the Remuneration Committee and the Science Committee.
Education: B.Sc. in chemistry, M.Sc. in biochemistry and Dr. Med.
Previous assignments: Founder and Managing Partner of Innovation Fund Denmark, member of the executive committee of IC Permed (the International Consortium of Personalized Medicine). Chair of the board in Scandion Oncology A/S, Prexton Therapeutics Ltd and Edvince AB, and member of the board in Monsenso A/S.
Other current assignments: Chair of the board KyNexis BV and Sidera Bio ApS. Owner and CEO of Hongaard Consulting Aps and Hongaard Holding. Member of the board Immunovia Incentive AB.
Dependency status: Independent in relation to the company and its management as well as to major shareholders.